Evidence map›Paper›PMID 41910240›Full record

ArticleApplied and environmental microbiology2026

Reduction of ferulic acid as an electron acceptor under anaerobic conditions by the heterofermentative lactic acid bacterium

Ryoji Mitsui, Hikaru Maruko, Riyo Awa, Fusako Kawamoto, Daigo Iwasaki, Yosuke Nishitani, Hiroshige Kuwahara, Takanori Yano

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Applied and environmental microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ryoji MitsuiDepartment of Bioscience, Faculty of Life Science, Okayama University of Science, Ridai-cho, Kita-ku, Okayama, Japan.ORCID 0000-0001-5741-8203
Hikaru MarukoDepartment of Bioscience, Faculty of Life Science, Okayama University of Science, Ridai-cho, Kita-ku, Okayama, Japan.
Riyo AwaResearch Center, Maruzen Pharmaceuticals Co., Ltd., Fukuyama, Hiroshima, Japan.
Fusako KawamotoResearch Center, Maruzen Pharmaceuticals Co., Ltd., Fukuyama, Hiroshima, Japan.
Daigo IwasakiResearch Center, Maruzen Pharmaceuticals Co., Ltd., Fukuyama, Hiroshima, Japan.
Yosuke NishitaniResearch Center, Maruzen Pharmaceuticals Co., Ltd., Fukuyama, Hiroshima, Japan.
Hiroshige KuwaharaResearch Center, Maruzen Pharmaceuticals Co., Ltd., Fukuyama, Hiroshima, Japan.
Takanori YanoDepartment of Bioscience, Faculty of Life Science, Okayama University of Science, Ridai-cho, Kita-ku, Okayama, Japan.

Funding

METI R&D Support Program for Growth-oriented Technology SMEs JPJ005698
6 · The paper itself

Abstract

When the heterofermentative lactic acid bacterium

Indexed as

Coumaric AcidsWeissellaAnaerobiosisBacterial ProteinsEscherichia coliFermentationLactic AcidOxidation-ReductionBacterial ProteinsCoumaric Acidsferulic acidLactic AcidFarAFarBferulic acidheterolactic fermentationHMPAlactic acid bacteriaredox balanceWeissella cibaria

Identifiers

PMID41910240
PMCPMC13101492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.